Delivery Order SPE2DE21D0005-SPE2D625F16XN

Award Date 1/7/25
Potential Completion Date 1/10/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, valued at $2,479.90, is a delivery order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The award is for the supply of the APLIGRAF advanced wound care product, a specialized skin substitute and tissue regeneration solution used in medical treatments. The contract does not utilize any set-aside...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $3,719.85 to Organogenesis Inc., a leading regenerative medicine company. The contract is for the supply of the APLIGRAF product, which is an advanced wound care and tissue regeneration solution. Organogenesis is a for-profit organization and manufacturer of goods that has held various federal contracts, including a $30 million multiple-award Federal Supply Schedule contract with the...
This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $2,479.90 fixed-price with economic price adjustment delivery order contract is for the supply of the advanced wound care product APLIGRAF. Organogenesis is the prime contractor, and there is no set-aside designation for this award. The company has previously received federal contracts through small business programs and...
This federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, is a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F35N5) placed by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of APLIGRAF, an advanced wound care product. The award is not associated with a set-aside program and is a Fixed Price with Economic Price Adjustment contract type. Organogenesis has a strong track record of providing...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F4995, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF advanced wound care product. Organogenesis, a for-profit manufacturer of goods, is a long-standing federal contractor, providing a range of tissue regeneration, wound care, and surgical biologics products to government...
This contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF medical products. The $1,239.95 fixed-price delivery order falls under a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a Defense agency, for wound care dressings, discs, and other medical materials. Organogenesis has also secured additional federal contracts with the Department of Veterans Affairs...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF, a specialized wound care product. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 27, 2024. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F16XN
    Delivery Order

This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue regeneration products. The awarded contract is for APLIGRAF, a skin substitute product used in medical treatments, particularly for military personnel and veterans. While this specific award does not utilize a set-aside designation, Organogenesis has received previous contracts through small business programs. The company maintains several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, demonstrating its robust presence in government medical procurement.

Generated 4/8/25, 9:45 AM